153 related articles for article (PubMed ID: 9192804)
21. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro.
Campbell MJ; Hamilton B; Shoemaker M; Tagliaferri M; Cohen I; Tripathy D
Anticancer Res; 2002; 22(6C):3843-52. PubMed ID: 12553004
[TBL] [Abstract][Full Text] [Related]
22. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
24. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
25. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL
Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276
[TBL] [Abstract][Full Text] [Related]
26. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
27. A novel design of targeted endocrine and cytokine therapy for breast cancer.
Zhang G; Li W; Holle L; Chen N; Chen WY
Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
[TBL] [Abstract][Full Text] [Related]
28. Melatonin and mammary pathological growth.
Cos S; Sánchez-Barceló EJ
Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
[TBL] [Abstract][Full Text] [Related]
29. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
30. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Anzano MA; Byers SW; Smith JM; Peer CW; Mullen LT; Brown CC; Roberts AB; Sporn MB
Cancer Res; 1994 Sep; 54(17):4614-7. PubMed ID: 8062253
[TBL] [Abstract][Full Text] [Related]
31. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
32. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
[TBL] [Abstract][Full Text] [Related]
33. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].
Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y
Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of a rat model for locally recurring mammary tumors: sensitivities to 5-fluoro-2'-deoxyuridine, adriamycin, and X-irradiation.
Welch DR; Aeed PA; Estrada J
Cancer Res; 1988 Aug; 48(16):4549-54. PubMed ID: 2969281
[TBL] [Abstract][Full Text] [Related]
35. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production.
Lewko WM; Liotta LA; Wicha MS; Vonderhaar BK; Kidwell WR
Cancer Res; 1981 Jul; 41(7):2855-62. PubMed ID: 7018671
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
38. Polyamines as mediators of the effect of prolactin and growth hormone on the growth of N-nitroso-N-methylurea-induced rat mammary tumor cultured in vitro in soft agar.
Manni A; Wright C
J Natl Cancer Inst; 1985 Apr; 74(4):941-4. PubMed ID: 3857388
[TBL] [Abstract][Full Text] [Related]
39. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo.
Sun RC; Fadia M; Dahlstrom JE; Parish CR; Board PG; Blackburn AC
Breast Cancer Res Treat; 2010 Feb; 120(1):253-60. PubMed ID: 19543830
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a sheep pituitary-derived growth factor for rat and human mammary tumor cells.
Ikeda T; Danielpour D; Sirbasku DA
J Cell Biochem; 1984; 25(4):213-29. PubMed ID: 6334689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
